ascopubs.org

Prognostic value of the absolute lymphocyte count reduction in patients with diffuse large B-cell lymphoma treated with R-CHOP.

Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL). 18F-fluorodeoxglucose (FDG) positron emission tomography (PET) versus FLIPI as a ...
ascopubs.org

The prognostic significance of prenephrectomy absolute lymphocyte count in clear cell renal cell carcinoma.

Impact of 24 months of androgen deprivation therapy (ADT) on physical function in men with nonmetastatic prostate cancer. A phase II study of neoadjuvant docetaxel (D) plus bevacizumab (B) in patients ...
Healio

‘Readily available biomarker’ can predict outcomes in multiple myeloma

Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...
Sun Journal

Decade-long high lymphocyte count isn’t cause for concern

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a female and almost 75 years old. My vital signs are ...
EurekAlert!

Analysis of Lymphocyte Subset Differences and Correlations Among the Three Groups. (IMAGE)

(A) Principal component analysis (PCA) of lymphocyte subsets and factors such as age in Control, LC, and LC-PTB groups, and the joint analysis of LC & LC-PTB. PC1 and PC2 represent the first and ...
Seeking Alpha

ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lung Cancer

CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (IBRX) (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA (nogapendekin alfa inbakicept) ...